Niagen Bioscience (NAGE) announced it has partnered with Truemed to allow qualified customers to purchase Tru Niagen using health savings account and flexible spending account funds on its website. Customers can use these funds with a Truemed letter of medical necessity issued by a licensed provider. “Truemed exists to make preventive health tools more financially accessible,” said Justin Mares, co-founder and CEO of Truemed. “We are excited to help qualified customers use HSA/FSA funds to support their healthspan with Tru Niagen.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAGE:
- Niagen Bioscience: Strengthened NR Patent Control and Differentiated Efficacy Support Buy Rating and $14 Target
- Niagen Bioscience Secures Full Ownership of Key NR Patents
- Niagen Bioscience acquires existing nicotinamide riboside patent portfolio
- Niagen Bioscience management to meet with Roth Capital